Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy
- PMID: 8008003
- DOI: 10.1002/mus.880170710
Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy
Abstract
The diagnosis of paramyotonia congenita (PC) can be aided by demonstrating a decrease in compound motor action potential amplitude after exercise and a decrement on repetitive stimulation, following cold exposure. We report a patient with PC who presented with complaints of cold-induced hand and jaw stiffening, in the absence of any episodes of weakness. Treatment with mexiletine led to resolution of the abnormalities exhibited during a short exercise test and repetitive stimulation following ice bath immersion. Molecular genetic analysis revealed a missense mutation (cytosine to thymidine) on chromosome 17 in the alpha-subunit of the skeletal muscle sodium channel gene that results in the replacement of threonine with methionine. This case demonstrates that, despite the absence of weakness, the short exercise test following cold exposure can be used to confirm the diagnosis of PC in patients without episodic weakness. Furthermore, improvement of the electrophysiologic abnormalities with mexiletine was documented, corresponding with clinical improvement.
Similar articles
-
[Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine].Rev Neurol (Paris). 1983;139(11):665-72. Rev Neurol (Paris). 1983. PMID: 6677978 French.
-
Paramyotonia congenita: successful treatment with tocainide. Clinical and electrophysiologic findings in seven patients.Muscle Nerve. 1987 Feb;10(2):155-62. doi: 10.1002/mus.880100209. Muscle Nerve. 1987. PMID: 3102961
-
Distinguishing paramyotonia congenita and myotonia congenita by electromyography.Muscle Nerve. 1983 Jun;6(5):374-9. doi: 10.1002/mus.880060506. Muscle Nerve. 1983. PMID: 6888415
-
Paramyotonia congenita.Semin Neurol. 1991 Sep;11(3):249-57. doi: 10.1055/s-2008-1041229. Semin Neurol. 1991. PMID: 1947488 Review. No abstract available.
-
[Muscle weakness or rigidity due to hereditary ion channel diseases].Ned Tijdschr Geneeskd. 2001 Feb 10;145(6):249-51. Ned Tijdschr Geneeskd. 2001. PMID: 11236369 Review. Dutch.
Cited by
-
Inactivation defects caused by myotonia-associated mutations in the sodium channel III-IV linker.J Gen Physiol. 1996 May;107(5):559-76. doi: 10.1085/jgp.107.5.559. J Gen Physiol. 1996. PMID: 8740371 Free PMC article.
-
A practical and efficient route for the highly enantioselective synthesis of mexiletine analogues and novel beta-thiophenoxy and pyridyl ethers.J Org Chem. 2008 Sep 5;73(17):6928-31. doi: 10.1021/jo801181d. Epub 2008 Aug 9. J Org Chem. 2008. PMID: 18690744 Free PMC article.
-
Non-dystrophic myotonia: 2-year clinical and patient reported outcomes.Muscle Nerve. 2022 Aug;66(2):148-158. doi: 10.1002/mus.27649. Epub 2022 Jun 16. Muscle Nerve. 2022. PMID: 35644941 Free PMC article.
-
Characterization of a new sodium channel mutation at arginine 1448 associated with moderate Paramyotonia congenita in humans.J Physiol. 1999 Jul 15;518 ( Pt 2)(Pt 2):337-44. doi: 10.1111/j.1469-7793.1999.0337p.x. J Physiol. 1999. PMID: 10381583 Free PMC article. Clinical Trial.
-
Voltage-gated sodium channels in excitable cells as drug targets.Nat Rev Drug Discov. 2025 May;24(5):358-378. doi: 10.1038/s41573-024-01108-x. Epub 2025 Feb 3. Nat Rev Drug Discov. 2025. PMID: 39901031 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources